NPR's Marketplace reported this morning:
In the last few years, there's been such a spike in drug coupons, pharmaceutical companies have barely been able to print them fast enough.
Coupons help patients shoulder the cost of expensive prescriptions, but a new paper out in the New England Journal of Medicine finds certain coupons are also a windfall for drug companies. Harvard Business School economist Leemore Dafny, Northwestern’s Chris Ody and UCLA’s Matt Schmitt found when manufacturers issued coupons right before a generic competitor entered the market, branded drug sales soared by 60 percent.
The full NPR story is here.
